Thrilled to join Abbott Cardiovascular as the Chief Medical Officer for Vascular. The space is more exciting than ever, and Abbott is on the leading edge of innovation.

Thankful for 15yrs at Providence Oregon with extraordinary colleagues. So much good to come!
#AbbottProud #CardioTwitter

See you dear all friends on the 30th anniversary of TCTAP, Coex, Seoul again💝💝💝

61 y/o male. post MI 4y ago (DES to mid LAD). LDL 56 (statin). BMI 23. non-smoker. BP well conrolled. No metabolic disorter. eGFR >90. No FHx. Active & asymptomatic at high exertion.
.
Routine check-up c CCTA to check stent...
.
Proximal LAD: new high-risk plaque!

#CoronaryPhysiology
#Microcirculation

A N G I O - I M R in S T E M I 🤔

prognostic value

after PCI

in predicting adverse outcomes

👇
ahajournals.org/doi/abs/10.116…

👋 A Yidilisi
J Jiang 🇨🇳

Zhejiang University
#AccuIMR
#ArteryFlowTechnology

#CoronaryPhysiology
#Microcirculation

🫀MICROVASCULAR

RESISTANCE RESERVE:

PET/FFR before & after PCI

MRR
✅ INDEPENDENT of stenosis severity
🟰MICROVASCULATURE-specific

👇
atherosclerosis-journal.com/article/S0021-…

👋 M Hoshino
Nico Pijls
Tim van de Hoef
Paul Knaapen

#MRR
#PACIFICtrial

Impressive data from yoshinobu murasato at #TCTAP2024 around imaging use in lms pci in japan- 98%. In uk we're only at 75% nationally and US much less. Need to do better

#INOCA is not benign

🔹 MACE: 2% at 1y (CIAO ISCHEMIA), 1.32/100 person-year (MetaAnalysis 54 studies)

🔹Chest pain 🏥 : 4% at 1y (CIAO ISCHEMIA), 20% over 5y

Proper workup of INOCA to avoid MACE and high economic burder is necessary

#TCTAP2024
summitmd_cvrf

Do-Yoon Kang shows that in the complex pci subgroup of OCTIVUS no difference between ivus and oct- the main issue is to just inage. Framework presented re what you should use when summitmd_cvrf Duk-Woo Park Ziad Ali Hany Ragy Zille Huma #TCTAP2024 Antonious Attallah, MD, FACC, FSCAI Ahmed Sayed…

Akiko Maehara presenting data around eruptive vs non eruptive calcified nodulesand how they behave during pci. Much better expansion with eruptive nodules summitmd_cvrf Duk-Woo Park

🙏 Thank you summitmd_cvrf

for posting this

V I D E O

about Prof N I C O P I J L S

LIFE and many great ACHIEVEMENTS

👇
summitmd.com/html/technical…

Congratulations

Prof N I C O P I J L S !

🌟🎉🥳🍾🎈🌟🎆🥂❤️🌟

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

Angio-Based Physiology

to Guide Cases

🪜 Clear steps

on H O W to use it and

handy technical features 🛠️

ALL-RISE
outcomes study enrolling

👋William Fearon

#TCTAP
#summitmd_cvrf
summitmd_cvrf

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

The F A T E

of D E F E R R E D Lesions 🚫

Insights from

I R I S - F F R 🧿

Want to do MORE?

• Use I M A G I N G
to identify VULNERABILITY

• Do GOOD PCI

👋Jung-Min Ahn

#TCTAP
#summitmd_cvrf
summitmd_cvrf

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

🪜Step-by-Step

Physiological Assessment📈

To Accomplish

Physiology-Guided PCI 🫀

👋Hitoshi Matsuo

#TCTAP
#TCTAP Smiles
summitmd_cvrf

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

Intravascular Imaging 👀

in Complex PCI 🫀

How to Optimize ✅

LIVELY D I S C U S S I O N :

is B I G G E R really B E T T E R 🤔❓

#AdventitiaDamage

👋 Myeong-Ki Hong

#TCTAP
#TCTAP Smiles
summitmd_cvrf

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

Clinical Use 😷

of Intracoronary Imaging 👀

Guidance and Optimization ✅

of Coronary Interventions 🫀

👋Evelyn Regar

#TCTAP
#TCTAP Smiles
summitmd_cvrf

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

The Series of F A M E Studies ⭐️⭐️⭐️

A P A R A D I G M S H I F T

in Our Thinking 🤔

About Interventional Cardiology 🫀

👋William Fearon

#DrFearonInTheHouse
#TCTAP
#TCTAP Smiles
summitmd_cvrf

#CoronaryPhysiology
#IntravascularImaging

#TCTAP 2024

The O C T O B E R trial

🔟 lessons learned

from using O C T 👀

And

WHAT’s N E X T

👋Niels R. Holm

#TCTAP
#TCTAP Smiles
summitmd_cvrf

#CoronaryPhydiology
#IntravascularImaging
#TCTAP 2024

Coronary Physiology

& Intravascular Imaging

session

Happening now!

#TCTAP
#TCTAP Smiles
summitmd_cvrf